Applied DNA Sciences (NASDAQ:APDN) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a research report report published on Saturday. The brokerage issued a hold rating on the technology company’s stock.

Separately, HC Wainwright decreased their price objective on shares of Applied DNA Sciences from $2.00 to $1.50 and set a buy rating on the stock in a report on Friday, February 9th.

Applied DNA Sciences Trading Down 4.9 %

NASDAQ:APDN opened at $0.36 on Friday. Applied DNA Sciences has a 1-year low of $0.36 and a 1-year high of $1.86. The firm has a fifty day simple moving average of $0.51 and a 200 day simple moving average of $0.69. The stock has a market capitalization of $6.12 million, a PE ratio of -0.67 and a beta of 0.07.

Applied DNA Sciences (NASDAQ:APDN) last released its quarterly earnings data on Thursday, February 8th. The technology company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.31) by $0.22. Applied DNA Sciences had a negative net margin of 80.14% and a negative return on equity of 159.93%. The firm had revenue of $0.89 million for the quarter, compared to the consensus estimate of $0.70 million. On average, equities analysts predict that Applied DNA Sciences will post -0.63 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Applied DNA Sciences

Institutional investors have recently modified their holdings of the business. State Street Corp lifted its position in Applied DNA Sciences by 53.6% during the first quarter. State Street Corp now owns 26,977 shares of the technology company’s stock worth $58,000 after purchasing an additional 9,416 shares during the period. Vanguard Group Inc. lifted its position in Applied DNA Sciences by 3.4% during the third quarter. Vanguard Group Inc. now owns 523,691 shares of the technology company’s stock worth $634,000 after purchasing an additional 17,241 shares during the period. Atria Wealth Solutions Inc. lifted its position in Applied DNA Sciences by 32.2% during the fourth quarter. Atria Wealth Solutions Inc. now owns 83,110 shares of the technology company’s stock worth $138,000 after purchasing an additional 20,250 shares during the period. Dimensional Fund Advisors LP lifted its position in Applied DNA Sciences by 53.0% during the first quarter. Dimensional Fund Advisors LP now owns 65,916 shares of the technology company’s stock worth $141,000 after purchasing an additional 22,843 shares during the period. Finally, Virtu Financial LLC bought a new stake in Applied DNA Sciences during the first quarter worth about $49,000. Institutional investors own 22.22% of the company’s stock.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.